Men’s preferences for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia: a discrete choice experiment

Abstract

ObjectiveTo explore and quantify men’s preferences and willingness to pay (WTP) for attributes of medications for lower urinary tract symptoms associated with benign prostatic hyperplasia using a discrete choice experiment.Subjects and methodsMen in the UK aged ≥45 years with moderate-to-severe lower urinary tract symptoms/benign prostatic hyperplasia (based on self-reported International Prostate Symptom Score ≥8) were recruited. An online discrete choice experiment survey was administered. Eligible men were asked to consider different medication scenarios and select their preferred medication according to seven attributes: daytime and nighttime (nocturia) urinary frequency, urinary urgency, sexual and nonsexual side effects, number of tablets/day, and cost/month. A mixed-logit model was used to estimate preferences and WTP for medication attributes.ResultsIn all, 247 men completed the survey. Men were willing to trade-off symptom improvements and treatment side effects. Men preferred medications that reduced urinary urgency and reduced day- and nighttime urinary frequency. Men preferred medications without side effects (base-case level), but did not care about the number of tablets per day. WTP for symptomatic improvement was £25.33/month for reduced urgency (urge incontinence to mild urgency), and £6.65/month and £1.39/month for each unit reduction in night- and daytime urination frequency, respectively. The sexual and nonsexual side effects reduced WTP by up to £30.07/month. There was significant heterogeneity in preferences for most attributes, except for reduced urinary urgency from urge incontinence to mild urgency and no fluid during ejaculation (dry orgasm).ConclusionTo compensate for side effects, a medicine for lower urinary tract symptoms/benign prostatic hyperplasia must provide a combination of benefits, such as reduced urgency of urination plus reduced nighttime and/or reduced daytime urination.

What can discrete choice experiments do for you?

“…Although there is an extensive literature examining what is important to patients in terms of delivery of care, looking at what is valued in education and medical education is relatively new (see later in this paper for examples). Yet knowing what is valued by applicants, students, trainees and colleagues is of increasing importance in the higher education and medical job marketplaces.…”

Treatment decision‐making among men with lower urinary tract symptoms: A qualitative study of men's experiences with recommendations for patient‐centred practice

“…Most participants reported that assessment results were useful in treatment decision-making, providing a rationale for treatment; this reflects our previous finding that urodynamics is largely acceptable and valuable to patients. 12 As in other urological studies, 20 clinicians' opinions and patients' perceptions of surgery's invasiveness, risks (especially of incontinence and sexual dysfunction 21 ) and recovery time were important considerations. Unlike in a qualitative study in prostate cancer, 22 relatives played a supportive role rather than determining men's decision, perhaps due to the perceived higher stakes in cancer treatment decision-making.…”

Role of calcium channel blockers in lower urinary tract symptoms in benign prostatic hyperplasia: a literature review

“…Age is also another notable factor associated with nocturia [40]. Mankowski et al noted that men with LUTS/benign prostatic hyperplasia preferred treatment that relived both urgency and day time/night time micturition as a compensation for potential side effects [41]. Patients with BPH and LUTS have more bladder storage dysfunction, whereas patients with BPH and severe LUTS have higher grade of bladder outlet disorders associated symptoms [42].…”